Matricelf (Matricelf) EV-to-Revenue : (As of May. 26, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Matricelf EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Matricelf's enterprise value is $20.19 Mil. Matricelf does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Matricelf's EV-to-Revenue at this moment.

The historical rank and industry rank for Matricelf's EV-to-Revenue or its related term are showing as below:

MTRLF's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 8.18
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Matricelf's stock price is $1.90. Matricelf does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Matricelf's PS Ratio at this moment.

Matricelf EV-to-Revenue Historical Data

The historical data trend for Matricelf's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matricelf EV-to-Revenue Chart

Matricelf Annual Data

Trend

EV-to-Revenue

Matricelf Semi-Annual Data

EV-to-Revenue

Competitive Comparison of Matricelf's EV-to-Revenue

For the Biotechnology subindustry, Matricelf's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Matricelf's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Matricelf's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Matricelf's EV-to-Revenue falls into.

Matricelf EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Matricelf's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	20.185	/
	=

Matricelf (OTCPK:MTRLF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Matricelf's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.90	/
	=

Matricelf EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Matricelf's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Matricelf (Matricelf) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matricelf Ltd (OTCPK:MTRLF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

MTLF:Israel

Address

Golda Meir 3, Ness Ziona, ISR, 6701838

Website

https://www.matricelf.com

Matricelf Ltd is engaged in research and development in the field of medicine and tissue engineering. It is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions.

Matricelf (Matricelf) Headlines

From GuruFocus

Matricelf technology in treating paralysis due to chronic spinal cord injury in mice with the world's first 3D engineered neural tissue implant

By PRNewswire PRNewswire • 02-07-2022

Matricelf has reached a major milestone

By PRNewswire PRNewswire • 05-02-2022